Client-Centered Breastfeeding Support: Effects on Primipara Mothers in a Randomized Trial Breastfeeding Self-Efficacy, Attitudes, and Problems in Primiparous Mothers: A Randomized Controlled Trial
Launched by PAMUKKALE UNIVERSITY · Jun 1, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special support program designed to help first-time mothers (called primipara mothers) with breastfeeding. The goal is to see how this program affects mothers' confidence in breastfeeding, their attitudes towards it, and any challenges they face. Mothers who participate will receive guidance and support through an interactive model that encourages healthy behaviors. Their experiences and feelings about breastfeeding will be assessed at different points during the study to track any changes.
To join the study, mothers need to be first-time parents, have a baby due between 32-40 weeks, and be able to communicate easily. They should also own a smartphone and have completed at least primary school education. However, mothers with certain health issues or complications that could impact breastfeeding, as well as those undergoing fertility treatments, will not be eligible. This trial will compare the outcomes of mothers receiving the support program to those getting standard care, helping researchers understand the benefits of this tailored approach.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Primiparous mothers
- • Gestational age between 32-40 weeks
- • Ability to communicate effectively
- • Ownership of a smartphone
- • Minimum education level: primary school graduate
- Exclusion Criteria:
- • Infants with health issues
- • Mothers with medical or pregnancy-related complications that hinder breastfeeding (e.g., heart disease, cancer, nephritis, active or untreated tuberculosis, HIV/AIDS, active herpes lesions on the breast, severe malnutrition)
- • Participants undergoing infertility treatment with IVF
About Pamukkale University
Pamukkale University is a renowned academic institution located in Denizli, Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the broader scientific community. With a commitment to ethical standards and regulatory compliance, Pamukkale University fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring the rigorous execution of clinical trials that address critical health challenges. Through its research initiatives, the university aims to enhance the understanding of various medical conditions and support the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Denizli, Pamukkale, Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0